Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Heart Failure
Interventions
DEVICE

Heartfelt device

"The Heartfelt device uses a system of cameras in a compact device to generate 3D images of the feet and lower legs with a view to detecting early volume changes. The device can be installed on the wall or as a free standing unit; however, given the COVID-19 pandemic, only the free standing option will be available to participants, so as to avoid the necessity of an installer visiting the patient. For the measurements to take place, the participant walks in the field of view of the device. Participants are not expected to change anything to their routine. The device can also take measurements in the dark.~The switch between 'full data analysis' and 'technical checks only' modes can be done remotely, making the cross-over seamless.~In the event that an alert is generated by the device, a medical assessment will take place either by phone or face to face appointment to evaluate the participant's condition."

Trial Locations (1)

FY3 9NR

Department of Cardiology, Lancashire Cardiac Centre, Blackpool Teaching Hospitals NHS Foundation Trust (Blackpool Victoria Hospital), Whinney Heys Road., Blackpool

Sponsors
All Listed Sponsors
collaborator

Blackpool Teaching Hospitals NHS Foundation Trust

OTHER

lead

Heartfelt Technologies

INDUSTRY

NCT04787380 - Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure | Biotech Hunter | Biotech Hunter